U.S. flag An official website of the United States government
  1. Home
  2. Drug Databases
  3. Drugs@FDA

Drugs@FDA: FDA-Approved Drugs

Home | Previous Page

New Drug Application (NDA): 209777
Company: PROTEGA PHARMS
Drug Name Active Ingredients Strength Dosage Form/Route Marketing Status TE Code RLD RS
ROXYBOND OXYCODONE HYDROCHLORIDE 5MG TABLET;ORAL Prescription None No No
ROXYBOND OXYCODONE HYDROCHLORIDE 15MG TABLET;ORAL Prescription None No No
ROXYBOND OXYCODONE HYDROCHLORIDE 30MG TABLET;ORAL Prescription None No No
Original Approvals or Tentative Approvals
Action Date Submission Action Type Submission Classification Review Priority; Orphan Status Letters, Reviews, Labels, Patient Package Insert Notes Url
04/20/2017 ORIG-1 Approval Type 5 - New Formulation or New Manufacturer PRIORITY Label (PDF)
Letter (PDF)
Review
https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/209777lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2017/209777Orig1s000ltr.pdf https://www.accessdata.fda.gov/drugsatfda_docs/nda/2017/209777Orig1s000TOC.cfm
Supplements
Action Date Submission Supplement Categories or Approval Type Letters, Reviews, Labels, Patient Package Insert Note Url
03/04/2021 SUPPL-7 Labeling-Package Insert Label (PDF)
Letter (PDF)
https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/209777s007lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2021/209777Orig1s007ltr.pdf
10/07/2019 SUPPL-6 Labeling-Package Insert Label (PDF)
Letter (PDF)
https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/209777s006lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2019/209777Orig1s006ltr.pdf
09/18/2018 SUPPL-3 Labeling-Medication Guide, Labeling-Package Insert Label (PDF)
Letter (PDF)
https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/209777s001s003lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2018/209777Orig1s001s003ltr.pdf
12/31/2018 SUPPL-2 Labeling-Package Insert Label (PDF)
Letter (PDF)
https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/209777s002lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2018/209777Orig1s002ltr.pdf
09/18/2018 SUPPL-1 REMS - PROPOSAL - D-N-A Label (PDF)
Letter (PDF)
https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/209777s001s003lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2018/209777Orig1s001s003ltr.pdf
Action Date Submission Supplement Categories or Approval Type Letters, Reviews, Labels,
Patient Package Insert
Note Url
03/04/2021 SUPPL-7 Labeling-Package Insert Label (PDF) https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/209777s007lbl.pdf
10/07/2019 SUPPL-6 Labeling-Package Insert Label (PDF) https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/209777s006lbl.pdf
12/31/2018 SUPPL-2 Labeling-Package Insert Label (PDF) https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/209777s002lbl.pdf
09/18/2018 SUPPL-3 Labeling-Medication Guide Label (PDF) https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/209777s001s003lbl.pdf
09/18/2018 SUPPL-3 Labeling-Package Insert Label (PDF) https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/209777s001s003lbl.pdf
09/18/2018 SUPPL-1 REMS - PROPOSAL - D-N-A Label (PDF) https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/209777s001s003lbl.pdf
04/20/2017 ORIG-1 Approval Label (PDF) https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/209777lbl.pdf
Back to Top